Financhill
Sell
6

SLS Quote, Financials, Valuation and Earnings

Last price:
$0.90
Seasonality move :
2.47%
Day range:
$0.89 - $0.93
52-week range:
$0.50 - $1.72
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.03x
Volume:
648K
Avg. volume:
1.5M
1-year change:
-10.87%
Market cap:
$64M
Revenue:
--
EPS (TTM):
-$0.69

Earnings Data

Next earnings date for SLS
May 14
2025
Most recent earnings per share
-$0.10
Beat by $0.03
(Nov 13/2024)
Consensus Estimate
-$0.13
(Nov 13/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SLS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 -- -- -- -$0.11 --
11/13/2024 Q3 -- -- -$0.10 -$0.13 $0.03
08/13/2024 Q2 -- -- -$0.13 -$0.17 $0.04
05/14/2024 Q1 -- -- -$0.21 -$0.16 -$0.05
12/31/2023 Q4 $13M -- -$0.25 -$0.03 -$0.22
11/09/2023 Q3 -- -- -$0.33 $0.02 -$0.35
08/10/2023 Q2 -- -- -$0.31 -$0.36 $0.05
05/11/2023 Q1 -- -- -$0.47 -$0.29 -$0.18
12/31/2022 Q4 -- -- -$0.43 -$0.34 -$0.10
11/14/2022 Q3 -- -- -$0.34 -$0.39 $0.05
08/11/2022 Q2 -- -- -$0.41 -$0.37 -$0.04
05/12/2022 Q1 -- -- -$1.05 -$0.42 -$0.63
03/23/2022 Q4 -- -- -$0.42 -$0.41 -$0.01
11/12/2021 Q3 -- -- -$0.45 -$0.35 -$0.11
08/12/2021 Q2 -- -- -$0.30 -$0.39 $0.09
05/13/2021 Q1 -- -- -$0.16 -$0.36 $0.20
03/23/2021 Q4 -- -- -$0.28 -$0.36 $0.08
11/13/2020 Q3 -- -- -$0.53 -$0.34 -$0.19
06/30/2020 Q2 -- -- -$0.66 -$0.64 -$0.02
03/31/2020 Q1 -- -- -$0.66 -$0.68 $0.02
12/31/2019 Q4 -- -- -$1.46 -$0.84 -$0.62
11/15/2019 Q3 -- -- -$2.68 -$1.00 -$1.68
08/14/2019 Q2 -- -- -$6.20 -$9.00 $2.81
03/31/2019 Q1 -- -- -$9.71 -$10.25 $0.54
12/31/2018 Q4 -- -- -$20.00 -$15.50 -$4.50
12/31/2017 Q4 -- -- -- -$34.50 --

SELLAS Life Sciences Group Earnings Questions

  • How Much did SELLAS Life Sciences Group Generate in Revenue Last Quarter?

    SELLAS Life Sciences Group reported -- worth of top line sales in its most recent quarter.

  • Did SELLAS Life Sciences Group Beat Earnings Last Quarter?

    SELLAS Life Sciences Group announced earnings per share of -$0.10 which represents a beat of analyst forecast a -$0.13 per share.

  • Is SELLAS Life Sciences Group Profitable?

    SELLAS Life Sciences Group reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for SELLAS Life Sciences Group EPS Next Year?

    SELLAS Life Sciences Group's earnings are forecast to decrease from -$1.34 per share to -$1.10 per share next year representing a decrease of -59.95%.

  • When is SELLAS Life Sciences Group's Earnings Date?

    SELLAS Life Sciences Group's next earnings date is May 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is down 8.7% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is up 9.77% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is up 7.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock